contact@reversebodytime.com
Phone +370 5 277 3357
Sūduvių g. 74, Zujūnai,
14166 Vilniaus r. sav,
Lithuania.
contact@reversebodytime.com
Phone +370 5 277 3357
Sūduvių g. 74, Zujūnai,
14166 Vilniaus r. sav,
Lithuania.
Mission & Vision
Mission Statement: At RBT, our mission is to revolutionise healthcare by blending cutting-edge science with compassionate care, aiming to extend not just life, but the quality of life for every patient we serve. We are committed to transparency in all aspects of care, from treatment pricing to the publication of research outcomes, upholding our ethical responsibility to advance medicine in ways that are accessible and understandable to patients worldwide.
Vision Statement: We envision a future where medicine is proactive, addressing aging with strategies that reverse its effects, and where each person’s unique biology guides their care. Our goal is to make a global impact by partnering with international health organisations to bring regenerative medicine to underserved populations, ensuring that advanced healthcare is accessible to all.
Timeline and Key Milestones of Reverse Body Time (RBT):
Reverse Body Time is a dynamic and evolving leading business that has grown from its foundational research in regenerative medicine to a global leader in anti-aging therapies. The focus on advanced, personalised treatment plans and continuous innovation highlights its commitment to revolutionising global healthcare.
Foundation and Vision:
-
Early 2000s: Groundwork for the concept of Reverse Body Time is laid, focusing on regenerative medicine and anti-aging. The approach is rooted in the utilisation of stem cells, exosomes, peptides, and other innovative therapies.
-
2012: Establishment of Froceth, a GMP manufacturing company, which plays a crucial role in producing stem cell and peptide products under the RBT umbrella.
-
2014: RBT starts to expand its vision globally, focusing on transforming healthcare by offering advanced, personalised therapeutic solutions.
Expansion of Services:
-
Mid-2010s: RBT begins offering comprehensive anti-aging therapies, including Mesenchymal Stem Cells (MSCs), Exosomes, Peptides (e.g., FOXO4), Hormones, and Cytokine-Induced Killer (CIK) cells.
-
2019: Launch of additional services and products, including peptide vaccines and advanced therapeutic medicinal products (ATMPs).
Global Expansion:
-
2020: RBT adopts an aggressive global expansion strategy. They begin establishing partnerships in various regions, including Europe, North/South America, and Asia-Pacific.
-
2024: RBT’s new production facility, four times larger than the current one, is under construction, expected to be completed within 18 months, which will increase production capacity by up to 500%.
Innovative Products:
2024: RBT continues to innovate with a broad range of peptide products such as TB-500, BPC-157, MOTS-C, and more, designed to cater to anti-aging, tissue regeneration, and overall health.
Ongoing Research and Development:
2020s onwards: Continuous R&D to refine and expand therapeutic offerings, with a focus on personalised treatments and innovative therapies such as exosomes and cytokine-induced killer cells.
Timeline and Key Milestones of Reverse Body Time (RBT):
Reverse Body Time is a dynamic and evolving leading business that has grown from its foundational research in regenerative medicine to a global leader in anti-aging therapies. The focus on advanced, personalised treatment plans and continuous innovation highlights its commitment to revolutionising global healthcare.
Foundation and Vision:
-
Early 2000s: Groundwork for the concept of Reverse Body Time is laid, focusing on regenerative medicine and anti-aging. The approach is rooted in the utilisation of stem cells, exosomes, peptides, and other innovative therapies.
-
2012: Establishment of Froceth, a GMP manufacturing company, which plays a crucial role in producing stem cell and peptide products under the RBT umbrella.
-
2014: RBT starts to expand its vision globally, focusing on transforming healthcare by offering advanced, personalised therapeutic solutions.
Expansion of Services:
-
Mid-2010s: RBT begins offering comprehensive anti-aging therapies, including Mesenchymal Stem Cells (MSCs), Exosomes, Peptides (e.g., FOXO4), Hormones, and Cytokine-Induced Killer (CIK) cells.
-
2019: Launch of additional services and products, including peptide vaccines and advanced therapeutic medicinal products (ATMPs).
Global Expansion:
-
2020: RBT adopts an aggressive global expansion strategy. They begin establishing partnerships in various regions, including Europe, North/South America, and Asia-Pacific.
-
2024: RBT’s new production facility, four times larger than the current one, is under construction, expected to be completed within 18 months, which will increase production capacity by up to 500%.
Innovative Products:
2024: RBT continues to innovate with a broad range of peptide products such as TB-500, BPC-157, MOTS-C, and more, designed to cater to anti-aging, tissue regeneration, and overall health.
Ongoing Research and Development:
2020s onwards: Continuous R&D to refine and expand therapeutic offerings, with a focus on personalised treatments and innovative therapies such as exosomes and cytokine-induced killer cells.
Our Team
Our Valued Partners
Dr. Adas Darinskas
CSO - Founder
Dr. Adas Darinskas is a key member of our team at Reverse Body Time, bringing a profound expertise in cell technologies, immunology, and immune therapy. His work focuses on groundbreaking applications in treating cancer and autoimmune diseases. Dr. Darinskas is also deeply involved in studying the molecular mechanisms of aging, which informs our innovative approaches in regenerative medicine.
His passion for gene and tissue engineering drives our efforts to develop therapies that not only improve patient outcomes but also restore and enhance biological functions. Dr. Darinskas’s dedication is crucial as we explore the complex interactions between cellular processes and systemic health, continually advancing the frontiers of medical science at Reverse Body Time.
Edgaras Barodica
CEO - Founder
Edgaras is a seasoned leader and co-founder at Reverse Body Time, with a rich background in manufacturing, construction, and energy across global markets including Lithuania, the UK, Asia, Africa, Sweden, and Norway. His expertise in negotiation, business planning, and operations management drives our strategic development of advanced regenerative therapies. Fluent in English, German, Russian, Lithuanian, and Norwegian, Edgaras excels at forging international partnerships, significantly advancing our mission to innovate in the field of regenerative medicine.
Tomas Juska
COO - Founder
Tomas Juška, former CEO and one of the founders of “Libros Holdingas,” has a distinguished history of guiding large-scale expansions and strategic exits within Lithuania’s top industry service sectors. His expertise in growing and managing businesses like DOMINGOS PREKYBA and SINGLIS has refined his skills in forging strategic partnerships and driving business growth. At Reverse Body Time, Tomas applies his extensive experience to enhance our global operations, focusing on expanding our reach in the regenerative medicine and anti-aging market.
Justin Williams: CTIO
CTIO - Founder
Justin Williams is a visual design, branding, and technology expert with over 20 years of experience in 3D visualization, automation, and system development. As CTIO of Reverse Body Time (RBT), he drives digital infrastructure, clinical automation, and consumer interfaces, ensuring seamless scalability for global expansion.
Founder of Visual-Worx, he has led high-profile projects, including virtual reality training for Lockheed Martin and data visualization for BAE Defence Systems. His ability to merge technology, creativity, and strategic execution positions him at the forefront of health-tech innovation and regenerative medicine.
José Ávila
Partner - Spain
Expert in dental and medical innovation, with a focus on integrating biological dentistry with regenerative and personalised treatments. Strong global network across key healthcare markets.
Role at RBT: Facilitates strategic alliances between clinics, professionals, and GMP-certified laboratories, connecting the Spanish market with cutting-edge healthcare solutions.
Accolades: Leading efforts in the development of GMP-certified laboratories linked to hospital extensions in Marbella and Madrid.
Andy Mckay
Partner - Canada
Andy Mckay is an entrepreneur and strategist, with extensive experience as a CEO and founder of businesses in Canada and the UK. He specialises in digital building technologies and Digital Twins, bringing deep expertise in business development, financial management, and global outsourcing.
At RBT, he is responsible for driving expansion in Canada and Australia, streamlining operations and integrating research with digital transformation strategies. Recognised for optimising business workflows and enhancing operational efficiency, he plays a pivotal role in RBT’s global growth. His strategic execution supports RBT’s mission to scale regenerative healthcare solutions worldwide.
Vidar S. Osen
Partner - Norway
Serial entrepreneur with extensive experience across sales, management, logistics, supply chain, and business development. Proven track record in leading successful turnarounds and implementing strategic change processes.
Role at RBT: Brings deep expertise in operations, investments, and international business strategy to drive RBT’s expansion and optimise commercial partnerships.
Accolades: Seasoned executive with a wealth of experience in M&A, startups, real estate, and corporate governance, holding various board positions across industries.
.png)
.png)
.png)
.png)
.png)
.png)
At Reverse Body Time, our expert team in science and healthcare is dedicated to revolutionising the treatment of age-related, autoimmune, and degenerative diseases. With a mission to make advanced medical treatments accessible, we specialise in cutting-edge regenerative therapies that enhance health and longevity. Our state-of-the-art clinic in Lithuania features an ATMP manufacturing site and the nation’s only cGMP-certified adipose tissue bank.
We offer comprehensive therapies, from cellular treatments using stem cells to holistic care that supports patients throughout their journey. Committed to medical excellence, we collaborate closely to create personalised treatment plans based on the latest research, continually advancing the field of regenerative medicine through ongoing research and global partnerships.
Dr. Adas Darinskas
CSO - Founder
Dr. Adas Darinskas is a key member of our team at Reverse Body Time, bringing a profound expertise in cell technologies, immunology, and immune therapy. His work focuses on groundbreaking applications in treating cancer and autoimmune diseases. Dr. Darinskas is also deeply involved in studying the molecular mechanisms of aging, which informs our innovative approaches in regenerative medicine.
His passion for gene and tissue engineering drives our efforts to develop therapies that not only improve patient outcomes but also restore and enhance biological functions. Dr. Darinskas’s dedication is crucial as we explore the complex interactions between cellular processes and systemic health, continually advancing the frontiers of medical science at Reverse Body Time.
Edgaras Barodica
CEO - Founder
Edgaras is a seasoned leader and co-founder at Reverse Body Time, with a rich background in manufacturing, construction, and energy across global markets including Lithuania, the UK, Asia, Africa, Sweden, and Norway. His expertise in negotiation, business planning, and operations management drives our strategic development of advanced regenerative therapies. Fluent in English, German, Russian, Lithuanian, and Norwegian, Edgaras excels at forging international partnerships, significantly advancing our mission to innovate in the field of regenerative medicine.
Tomas Juska
COO - Founder
Tomas Juška, former CEO and one of the founders of “Libros Holdingas,” has a distinguished history of guiding large-scale expansions and strategic exits within Lithuania’s top industry service sectors. His expertise in growing and managing businesses like DOMINGOS PREKYBA and SINGLIS has refined his skills in forging strategic partnerships and driving business growth. At Reverse Body Time, Tomas applies his extensive experience to enhance our global operations, focusing on expanding our reach in the regenerative medicine and anti-aging market.
Justin Williams: CTIO
CTIO - Founder
Justin Williams is a visual design, branding, and technology expert with over 20 years of experience in 3D visualization, automation, and system development. As CTIO of Reverse Body Time (RBT), he drives digital infrastructure, clinical automation, and consumer interfaces, ensuring seamless scalability for global expansion.
Founder of Visual-Worx, he has led high-profile projects, including virtual reality training for Lockheed Martin and data visualization for BAE Defence Systems. His ability to merge technology, creativity, and strategic execution positions him at the forefront of health-tech innovation and regenerative medicine.
José Ávila
Partner - Spain
Expert in dental and medical innovation, with a focus on integrating biological dentistry with regenerative and personalised treatments. Strong global network across key healthcare markets.
Role at RBT: Facilitates strategic alliances between clinics, professionals, and GMP-certified laboratories, connecting the Spanish market with cutting-edge healthcare solutions.
Accolades: Leading efforts in the development of GMP-certified laboratories linked to hospital extensions in Marbella and Madrid.
Andy Mckay
Partner - Canada
Andy Mckay is an entrepreneur and strategist, with extensive experience as a CEO and founder of businesses in Canada and the UK. He specialises in digital building technologies and Digital Twins, bringing deep expertise in business development, financial management, and global outsourcing.
At RBT, he is responsible for driving expansion in Canada and Australia, streamlining operations and integrating research with digital transformation strategies. Recognised for optimising business workflows and enhancing operational efficiency, he plays a pivotal role in RBT’s global growth. His strategic execution supports RBT’s mission to scale regenerative healthcare solutions worldwide.
Vidar S. Osen
Partner - Norway
Serial entrepreneur with extensive experience across sales, management, logistics, supply chain, and business development. Proven track record in leading successful turnarounds and implementing strategic change processes.
Role at RBT: Brings deep expertise in operations, investments, and international business strategy to drive RBT’s expansion and optimise commercial partnerships.
Accolades: Seasoned executive with a wealth of experience in M&A, startups, real estate, and corporate governance, holding various board positions across industries.
Our Team
At Reverse Body Time, our expert team in science and healthcare is dedicated to revolutionising the treatment of age-related, autoimmune, and degenerative diseases. With a mission to make advanced medical treatments accessible, we specialise in cutting-edge regenerative therapies that enhance health and longevity. Our state-of-the-art clinic in Lithuania features an ATMP manufacturing site and the nation’s only cGMP-certified adipose tissue bank.We offer comprehensive therapies, from cellular treatments using stem cells to holistic care that supports patients throughout their journey. Committed to medical excellence, we collaborate closely to create personalised treatment plans based on the latest research, continually advancing the field of regenerative medicine through ongoing research and global partnerships.
Our Valued Partners
Mission & Vision
Mission Statement: At RBT, our mission is to revolutionise healthcare by blending cutting-edge science with compassionate care, aiming to extend not just life, but the quality of life for every patient we serve. We are committed to transparency in all aspects of care, from treatment pricing to the publication of research outcomes, upholding our ethical responsibility to advance medicine in ways that are accessible and understandable to patients worldwide.
Vision Statement: We envision a future where medicine is proactive, addressing aging with strategies that reverse its effects, and where each person’s unique biology guides their care. Our goal is to make a global impact by partnering with international health organisations to bring regenerative medicine to underserved populations, ensuring that advanced healthcare is accessible to all.